RARE
Ultragenyx Pharmaceutical Inc.
Halal Rating :
Last Price
$39.22
Last updated:
Market Cap
-
7D Change
-9.13%
1 Year Change
-12.12%
Company Overview
Industries
Exchange
Next Earnings Date
Ultragenyx Pharmaceutical Inc. is a biopharmaceutical company focused on developing novel products for the treatment of serious rare and ultra-rare genetic diseases. The company's portfolio includes approved therapies and product candidates targeting various rare diseases. They use multiple modalities including small molecules, protein replacement, monoclonal antibodies, and gene therapy to develop treatments.
Use of Interest
| Reporting Date | Total Revenue | Total Operating Expense | Interest Income | Interest Expense | Interest Income Ratio | Interest Expense Ratio |
|---|---|---|---|---|---|---|
| Sept. 30, 2024 | $139.49m | $287.19m | - | $15.71m | 0.00% | 5.47% |
| June 30, 2024 | $147.03m | $279.35m | - | $15.96m | 0.00% | 5.71% |
| March 31, 2024 | $108.83m | $290.03m | - | $15.85m | 0.00% | 5.46% |
Company Impact
Help us evaluate Ultragenyx Pharmaceutical Inc.'s impact from a halal perspective. Vote on the most significant aspect and submit any considerations that we may have missed.